Gut microbiota promotes obesity-associated liver cancer through pge2-mediated suppression of antitumor immunity.
Published version of a preprint
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Obesity increases the risk of cancers, including hepatocellular carcinomas (HCC). However, the precise molecular mechanisms through which obesity promotes HCC development are still unclear. Recent studies have shown that gut microbiota may influence liver diseases by transferring its metabolites and components. Here, we show that the hepatic translocation of obesity-induced lipoteichoic acid (LTA), a Gram-positive gut microbial component, promotes HCC development by creating a tumor-promoting microenvironment. LTA enhances the senescence-associated secretory phenotype (SASP) of hepatic stellate cells (HSC) collaboratively with an obesity-induced gut microbial metabolite, deoxycholic acid, to upregulate the expression of SASP factors and COX2 through Toll-like receptor 2. Interestingly, COX2-mediated prostaglandin E2 (PGE2) production suppresses the antitumor immunity through a PTGER4 receptor, thereby contributing to HCC progression. Moreover, COX2 overexpression and excess PGE2 production were detected in HSCs in human HCCs with noncirrhotic, nonalcoholic steatohepatitis (NASH), indicating that a similar mechanism could function in humans. Significance: We showed the importance of the gut–liver axis in obesity-associated HCC. The gut microbiota–driven COX2 pathway produced the lipid mediator PGE2 in senescent HSCs in the tumor microenvironment, which plays a pivotal role in suppressing antitumor immunity, suggesting that PGE2 and its receptor may be novel therapeutic targets for noncirrhotic NASH-associated HCC. Cancer Discov; 7(5); 522–38. ©2017 AACR. This article is highlighted in the In This Issue feature, p. 443
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, it has become apparent that toll‐like receptors (TLR), an innate immune receptor, can trigger SASP induction.48, 59, 60”
From Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer (2020) · cites this paper as [48]
In the citing paper
“COX‐2 induces overproduction of prostaglandin E2 (PGE2), resulting in suppression of anti–tumor immunity and progression of obesity‐associated HCC.48”
From Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer (2020) · cites this paper as [48]
In the citing paper
“TLR2 stimulation induces expression of SASP factors through the NF‐κB signaling pathway to promote development of obesity‐associated HCC.48”
From Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer (2020) · cites this paper as [48]
In the citing paper
“Recently TLR, an innate immune receptor which recognizes pathogen-associated molecular patterns (PAMPs) and damage associated molecular patterns (DAMPs), was shown to trigger induction of SASP (Davalos et al., 2013; Kawasaki and Kawai, 2014; Loo et al., 2017, 2020; Hari et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Loo et al., 2017
In the citing paper
“Lipoteichoic acid (LTA), a component of the cell wall of gram positive gut microbiota is recognized by TLR2 and induces expression of SASP components creating a tumor promoting micro environment that promotes development of obesity associated hepatocellular carcinoma (Loo et al., 2017).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Loo et al., 2017
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 1×
“4), consistent with previous reports (27).”
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613 · cited 2×
“Obesity has become a worldwide health problem and is known to increase the risk of diabetes, cardiovascular disease, and several types of cancer (1).”
BackgroundT cell exclusion, immune privilege, and the tumor microenvironment
Joyce, J. A., & Fearon, D. T. (2015) · Science · doi:10.1126/science.aaa6204 · Cited by 2,473 · cited 1×
“The PD-1 blockade can recover the functions of effector T cells, and an anti–PD-1 antibody is now being clinically used for the treatment of various cancers (48, 49).”
BackgroundA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“Indeed, the paracrine effects of SASP have been reported to be dependent on the surrounding cells (17), particularly on the p53 status of these cells (18).”
BackgroundObesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219 · cited 10×
“This recently identified phenotype of senescent cells involves secretion of a series of inflammatory cytokines, chemokines, matrix-remodeling factors, and growth factors (7), suggesting that the gut–liver axis plays a pivotal role in inducing cellular senescence of HSCs and liver tumorigenesis (4).”
BackgroundSelf-citationFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 1×
“This recently identified phenotype of senescent cells involves secretion of a series of inflammatory cytokines, chemokines, matrix-remodeling factors, and growth factors (7), suggesting that the gut–liver axis plays a pivotal role in inducing cellular senescence of HSCs and liver tumorigenesis (4).”
BackgroundAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Self-citationSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Research works printed but not linked: 1
- Forman, 2014, The global and regional burden of cancer, 16
Cited by
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
“Recently TLR, an innate immune receptor which recognizes pathogen-associated molecular patterns (PAMPs) and damage associated molecular patterns (DAMPs), was shown to trigger induction of SASP (Davalos et al., 2013; Kawasaki and Kawai, 2014; Loo et al., 2017, 2020; Hari et al., 2019).”
BackgroundUnmasking senescence: context-dependent effects of SASP in cancer
Faget, D. V., Ren, Q., & Stewart, S. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0156-2 · Cited by 863
Zhang, X., Coker, O. O., Chu, E. S., Fu, K., Lau, H. C. H., Wang, Y.-X., Chan, A. W. H., Wei, H., Yang, X., Sung, J. J. Y., et al. (2021) · Gut · doi:10.1136/gutjnl-2019-319664 · Cited by 841
Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence
Kerr, J., Anderson, C., & Lippman, S. M. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30411-4 · Cited by 677
Metadata
- Authors
- Loo, T. M., Kamachi, F., Watanabe, Y., Yoshimoto, S., Kanda, H., Arai, Y., Nakajima-Takagi, Y., Iwama, A., Koga, T., Sugimoto, Y., Ozawa, T., Nakamura, M., Kumagai, M., Watashi, K., Taketo, M. M., Aoki, T., Narumiya, S., Oshima, M., Arita, M., Hara, E., & Ohtani, N.
- Affiliations
- Tokyo University of Science (JP)
- Japanese Foundation For Cancer Research (JP)
- 5Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Chiba University (JP)
- Kumamoto University (JP)
- National Institute of Infectious Diseases (JP)
- Kyoto University (JP)
- Kanazawa University (JP)
- Keio University (JP)
- Japan Agency for Medical Research and Development (JP)
- ORCID
- Venue
- Cancer Discovery
- Published
- 2017-04-30
- Volume
- 7
- Issue
- 5
- Pages
- 522-538
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2588201913
- Semantic Scholar
- d170c622d8ac72567e131da3c3405f2b4094f88b
- Cited by
- 478
- References
- 49
- Citations by year
- 2026: 35 · 2025: 51 · 2024: 58 · 2023: 66 · 2022: 74 · 2021: 72 · 2020: 50 · 2019: 33 · 2018: 27 · 2017: 12
- FWCI
- 13.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (26670030, 15H04648, 14J06998, 17H01531, 26250028, 15K12709, 15H05898, 16H04699, 15K19031, 17H03990, 15H05905, 16H06276, 26460565, 15H05897)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- gut microbiota, obesity, hepatocellular carcinoma, lipoteichoic acid, deoxycholic acid, hepatic stellate cells, senescence-associated secretory phenotype, cyclooxygenase-2, prostaglandin E2, EP4 receptor, TLR2, antitumor immunity, gut-liver axis, nonalcoholic steatohepatitis, tumor microenvironment
- MeSH terms
- Gastrointestinal Microbiome, Animals, Female, Carcinoma, Hepatocellular, Humans, Lipopolysaccharides, Liver Neoplasms, Male, Mice, Inbred C57BL, Obesity, Teichoic Acids, Dinoprostone, Tumor Escape, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gut microbiota promotes obesity-associated liver cancer through pge2-mediated suppression of antitumor immunity. https://app.cochat.ai/papers/10.1158/2159-8290.cd-16-0932
- The paper
- Loo, T. M., Kamachi, F., Watanabe, Y., Yoshimoto, S., Kanda, H., Arai, Y., Nakajima-Takagi, Y., Iwama, A., Koga, T., Sugimoto, Y., Ozawa, T., Nakamura, M., Kumagai, M., Watashi, K., Taketo, M. M., Aoki, T., Narumiya, S., Oshima, M., Arita, M., . . . Ohtani, N. (2017). Gut microbiota promotes obesity-associated liver cancer through pge2-mediated suppression of antitumor immunity. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-16-0932
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.